Biological value should be determined by what works in the world.

Plant biotechnology has to pass through scientific, regulatory, financial, commercial, and organizational systems before it can affect the physical world. Those systems are necessary, but each sees only part of the problem.

A trait can be biologically powerful while being difficult to finance or regulate. Another can fit existing institutional pathways while producing weaker physical outcomes. When those categories are confused, the requirements of the institution begin to determine what is treated as biologically valuable.

Carbocene treats regulation, propagation, field performance, financing, standards, market structure, and long timelines as constraints to specify and work through—not as substitutes for evidence about what the biology actually does.

Biotechnology institutions necessarily work through representations: regulatory categories, financing models, product definitions, milestones, market forecasts, and measurements. These tools make coordinated action possible. They become dangerous when success within the representation begins to stand in for success in the underlying physical system.

Carbocene is designed around the opposite ordering. Biological efficacy and physical outcomes remain primary. Financing, regulation, commercialization, philanthropy, licensing, and partnerships are different mechanisms for carrying useful biology forward.

Carbocene builds on years of plant-biotechnology research initiated at Living Carbon, including engineered aspen and conifer programs. When Living Carbon discontinued development and commercialization of its synthetic-biology tree program, Carbocene was established in its present nonprofit form as an independent pathway for continued research and new development.

By that transition, the work already extended from industrial propagation and repeated lead-event validation to replicated field experiments, advanced loblolly pine (Pinus taeda) event selection, and functioning eastern cottonwood (Populus deltoides) transformation. The institutional pathway changed; the biological questions remained.

Carbocene’s intellectual origins precede Living Carbon. Patrick began developing the framework at the 2019 Foresight Planeteers workshop around biological productivity, carbon flux, decomposition, durable materials, and the integration of engineered plants into larger physical systems. He subsequently developed the work with Linda Maepa and Rob Ferber. Living Carbon became one important setting in which parts of this program were developed. Carbocene now pursues the broader program independently.

Regulatory categories, financing models, product definitions, and organizational milestones matter because they shape how useful biology reaches the world. They should not substitute for the question of whether the biology itself works.

Commercial products, licensing, industrial partnerships, grants, philanthropy, and productive land use can each support continued development.

Carbocene works toward living systems with greater functional connectivity, energy retention, resilience, and capacity for future development.

Living systems capture energy, retain it, recursively transform it, and use it to generate further organization. The ethical direction is systemic functional improvement: greater retention, communication, reciprocal organization, and room for living systems to adapt.

Interventions are judged through productivity, ecological relationships, resilience, material persistence, and future biological possibility alongside yield and carbon accounting.

We work toward ecologies in which human knowledge becomes a responsible participant.